The worldwide CAR T-cell therapy market is experiencing remarkable growth, driven by increasing demand for advanced cancer treatment options. This rapid expansion is fueled by factors such as the approval of CAR T-cell therapies for diverse indications, advancements in production technologies, and expanding research and development initiatives. Ad